Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

KURA - Kura Oncology, Inc. Financial Statements | Finranks

Home

/

KURA

K

Kura Oncology, Inc. (KURA)

NMS – Real Time Price. Currency in USD

9.94

+0.01 (0.10%)

Market open: Aug 12, 2026, 10:13 AM EDT

9.96

+0.03 (0.34%)

Previous after-hours: Aug 11, 2026, 7:54 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

67M

54M

0

0

Cost of goods sold

-1M

-848K

-849K

-759K

Gross Profit

66M

53M

-849K

-759K

Operating expenses (excl. COGS)

-370M

-246M

-165M

-139M

Operating Income

-304M

-193M

-166M

-140M

Non-operating income, total

25M

21M

13M

4M

Pretax income

-278M

-172M

-153M

-136M

Equity in earnings

0

0

0

0

Taxes

-297K

-2M

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-279M

-174M

-153M

-136M

Discontinued operations

0

0

0

0

Net income

-279M

-174M

-153M

-136M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

738M-29.0%

1.04B+131.8%

449M-1.6%

456M

Total current assets

709M

745M

432M

446M

Total non-current assets

30M

296M

16M

10M

Total liabilities

564M-10.0%

627M+1113.7%

52M+43.4%

36M

Total current liabilities

117M

79M

35M

24M

Total non-current liabilities

447M

548M

16M

12M

Total equity

174M

414M

397M

420M

Total liabilities & shareholders' equities

738M

1.04B

449M

456M

Total debt

20M+23.3%

17M-3.5%

17M+22.6%

14M

Name

2025

2024

2023

2022

Cash from operating activities

-64M

134M

-125M

-110M

Cash from investing activities

-13M

-102M

16M

33M

Cash from financing activities

2M

154M

95M

39M

Free cash flow

-71M-152.8%

134M+207.1%

-125M-12.9%

-111M